REGISTERED
on 14 May 2024
Last Applicant/ Owned by
1/F, Engine Room, No.212,
Suzhou, Jiangsu
CN
215000
Serial Number
97575705 filed on 01st Sep 2022
Registration Number
7389142 registered on 14th May 2024
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
EUFRAIN
The wording "Eufrain" has no meaning in a foreign language. Antiallergic medicines; aseptic cotton; dietetic foods adapted for medical use; mineral salts for medical purposes; nasal cleaning preparations for medical purposes; nasal drops for the treatment of allergies; nasal rinse; pharmaceutical preparations for treating allergic rhinitis; sodium salts for medical purposes; water-based personal Read More
Classification Information
Class [005]
Pharmaceutical Products
Antiallergic medicines; aseptic cotton; dietetic foods adapted for medical use; mineral salts for medical purposes; nasal cleaning preparations for medical purposes; nasal drops for the treatment of allergies; nasal rinse; pharmaceutical preparations for treating allergic rhinitis; sodium salts for medical purposes; water-based personal lubricants
First Use Date in General
11th Jan 2023
First Use Date in Commerce
11th Jan 2023
Mark Details
Serial Number
No 97575705
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 14th May 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 14th May 2024 | REGISTERED-PRINCIPAL REGISTER |
| 11th Apr 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 10th Apr 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 20th Mar 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 20th Mar 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 28th Feb 2024 | TEAS STATEMENT OF USE RECEIVED |
| 28th Feb 2024 | USE AMENDMENT FILED |
| 19th Sep 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 25th Jul 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |